David Fuller
Technik-/Wissenschafts-/F&E-Leiter bei DIMERIX LIMITED
Vermögen: 1 869 $ am 31.05.2024
Aktive Positionen von David Fuller
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ADALTA LIMITED | Direktor/Vorstandsmitglied | 22.07.2020 | - |
DIMERIX LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 23.10.2023 | - |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Vorsitzender | - | - |
Karriereverlauf von David Fuller
Ehemalige bekannte Positionen von David Fuller
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RACE ONCOLOGY LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2021 | 11.11.2022 |
Statistik
International
Australien | 5 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 1 |
Chairman | 1 |
Sektoral
Health Technology | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ADALTA LIMITED | Health Technology |
RACE ONCOLOGY LIMITED | Health Technology |
DIMERIX LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Health Technology |
- Börse
- Insiders
- David Fuller
- Erfahrung